Brief: Nanoviricides Announces $2.5 Mln Financing In A Registered Direct Offering
27/02/2019 16:10
Feb 27 (Reuters) - NanoViricides Inc NNVC.A :
* NANOVIRICIDES ANNOUNCES $2.5 MILLION FINANCING IN A
REGISTERED
DIRECT OFFERING
* NANOVIRICIDES - ENTERED INTO SECURITIES PURCHASE AGREEMENT
WITH
CERTAIN INSTITUTIONAL INVESTORS FOR PURCHASE & SALE OF 6.9
MILLION UNITS AT $0.36 PER UNIT
Source text for Eikon: ID:nPn5fZWF8a
Further company coverage: NNVC.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on NanoViricides,
See all newsExplainer: What do we know about the Bundibugyo strain of the Ebola virus?
Brief: anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles
Brief: Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model
Brief: Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments
Brief: Nanoviricides Obtained Right Of First Refusal For All Antiviral Drug Developments